SEC Tracker
Get the app
ELTX · XBRL financial data

Elicio Therapeutics financial statements, every quarter

The same tables from 12 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

Download Excel Download CSV
How these numbers work
  • Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
  • Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
  • * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
  • 0 means a filing states zero; a dash (—) means no filing states that number.
  • “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
  • Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
  • Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
  • Shares outstanding come from each filing's cover page, as of the date printed there.
  • Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

CSV

Fiscal quarters (ELTX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Research and development7,2646,157*7,5598,1807,20810,709*7,7787,0065,0395,080*6,7576,811
General and administrative3,5073,235*2,6822,7443,1362,767*2,9583,0853,0063,762*3,8453,618
Operating income (loss)(10,771)(9,392)*(10,241)(10,924)(10,344)(13,476)*(10,736)(10,091)(8,045)(8,842)*(10,602)(10,429)
Interest income246——137185—210168199—157138
Interest expense12*3649137234*176194426337*407410
Income tax expense (benefit)00*0000*0000*00
Net income (loss)(10,658)(8,949)*(11,827)(7,229)(18,838)(14,004)*(11,209)(10,561)(10,083)(7,718)*(11,823)(8,217)
Earnings per share, basic USD per share(1.27)—(1.15)(0.64)(1.39)(1.03)*(0.87)(0.66)(0.60)(0.50)*(0.65)(0.43)
Earnings per share, diluted USD per share(1.27)—(1.15)(0.64)(1.39)(1.03)*(0.87)(0.66)(0.60)(0.50)*(0.65)(0.43)
Weighted average shares, basic thousands of shares8,376—10,27411,28513,58213,640*12,95116,05916,69215,505*18,21219,245
Weighted average shares, diluted thousands of shares8,376—10,27411,28513,58213,640*12,95116,05916,69215,505*18,21219,245

Balance sheet

CSV

Fiscal quarters (ELTX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Cash and cash equivalents14,84112,89411,8533,42526,01617,61818,35122,08820,61118,56314,94823,480
Prepaid and other current assets3,4192,7321,6122,8683,3121,8971,9015108547481,2522,005
Total current assets19,93116,34814,1306,68930,64620,69320,93522,59821,46519,31116,20025,485
Property and equipment, net772717635597523483430377328295249213
Right-of-use asset6,7686,5636,3546,1425,9265,7065,4815,2535,0194,7824,5394,292
Total assets30,98727,14624,48015,75038,38828,17828,14429,52828,28425,86222,68931,330
Accounts payable4,4064,3691,1051,0551,9841,0384,0373,865321672272839
Accrued liabilities4,4163,7573,3245,3214,8528,4155,7705,1065,2136,4275,9157,290
Total current liabilities11,4869,7665,9517,5859,02011,52311,4139,9236,5158,1107,2299,202
Long-term debt—————20,034—9,3379,7209,4079,4759,535
Lease liability, non-current6,2156,0075,7915,5655,3385,1054,8654,6134,3564,0943,8233,540
Total liabilities17,70115,77319,61017,40257,37439,49019,24027,69424,46824,22624,12623,393
Accumulated deficit(133,254)(142,203)(154,030)(161,259)(180,097)(194,101)(205,310)(215,871)(225,954)(233,672)(245,495)(253,712)
Total stockholders' equity13,28611,3734,870(1,652)(18,986)(11,312)8,9041,8343,8161,636(1,437)7,937
Total liabilities and equity30,98727,14624,48015,75038,38828,17828,14429,52828,28425,86222,68931,330
Common shares outstanding (cover page) thousands of shares8,40710,23510,27010,77510,79115,95415,99716,33817,49018,39619,08626,282

Cash flows

CSV

Fiscal quarters (ELTX's year ends in late December)

In thousands of dollarsSep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
Net income (loss)(10,658)(8,949)*(11,827)(7,229)(18,838)(14,004)*(11,209)(10,561)(10,083)(7,718)*(11,823)(8,217)
Stock-based compensation339*337*324350*314*464*517710*698*772*868935*
Net cash from operating activities(5,184)*(9,896)*(12,122)(8,928)*(7,274)*(8,744)*(10,119)(8,950)*(11,086)*(6,797)*(11,645)(8,165)*
Purchases of property and equipment45*0*042*0*45*——0*16*——
Net cash from investing activities(45)*0*3(42)*0*(45)*00*0*(16)*——
Proceeds from issuing common stock0*6,999*5,062303*48*(858)*8352,016*—year only——
Net cash from financing activities59*7,002*11,024316*30,754*227*10,32811,932*9,572*4,863*8,02716,510*
Net change in cash(5,168)*(2,894)*(1,095)(8,695)*23,516*(8,535)*2403,056*(1,475)*(2,046)*(3,613)8,341*

Compare with peers

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.